Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Clinical trial NCT04242199 · COMPLETED

Trial details

NCT number: NCT04242199
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor MSI-H/dMMR Tumors Cutaneous Squamous Cell Carcinoma Urothelial Carcinoma Cervical Cancer HepatoCellular Carcinoma Esophageal Squamous Cell Carcinoma Merkel Cell Carcinoma Small-cell Lung Cancer Mesothelioma PD-L1 Amplified Tumor (9p24.1)Nasopharyngeal Carcinoma

Start date: 2020-09-04
Primary completion: 2024-08-29
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.